Regencell Bioscience Holdings Limited
RGC
Rankning i aktier
#3470
Regencell Bioscience Holdings Limited is a biotechnology firm specializing in... Regencell Bioscience Holdings Limited is a biotechnology firm specializing in Traditional Chinese Medicine (TCM). Its core activities revolve around the research, development, and market introduction of TCM solutions specifically designed to address neurocognitive disorders and related degeneration. The company places a particular emphasis on conditions such as attention deficit hyperactivity disorder (ADHD) and autism spectrum disorder (ASD). Established in 2014, Regencell Bioscience maintains its primary office in Causeway Bay, Hong Kong.
Aktiekurs
$9.85
Marknadsvärde
$4.88B
Förändring (1 dag)
-8.80%
Förändring (1 år)
-37.46%
Land
HK
Handel Regencell Bioscience Holdings Limited (RGC)
Kategori
Healthcare
Aktiekurshistorik för Regencell Bioscience Holdings Limited (RGC)
Högsta slutkurs: $8.35 den 2026-10-01
Lägsta slutkurs: $0.24 den 2021-07-01
Lägsta slutkurs: $0.24 den 2021-07-01
Aktiekurshistorik för Regencell Bioscience Holdings Limited från 2021 till 2026
Årlig aktiekursutveckling
| År | Prestanda |
|---|---|
| 2026 (TTM) | -1.78% |
| 2025 | 13,046.47% |
| 2024 | -47.20% |
| 2023 | -66.01% |
| 2022 | 8.50% |
| 2021 | 0.00% |
Aktiekurs för liknande företag eller konkurrenter
| Företag | Aktiekurs | Förändring 1år% | Land |
|---|---|---|---|
| $171.67 | - |
DE
|
|
| $165.31 | 23.62% |
DE
|
|
| $40.45 | 43.11% |
JP
|
|
| $224.81 | 31.28% |
CH
|
|
| $18.43 | -4.03% |
IN
|
